Skip to content

Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method

Comparaison de la Douleur Lors de la Pose Des DIU et SIU Entre la méthode Classique et la méthode Directe

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03473717
Acronym
KIDDS
Enrollment
158
Registered
2018-03-22
Start date
2018-03-30
Completion date
2019-03-15
Last updated
2018-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IUD Insertion

Keywords

pain, Intrauterine device (IUD), Intrauterine system (IUS), Patient-Reported Outcome

Brief summary

The so-called direct method of intrauterine device (IUD) and intraintuerine system (IUS) insertion is increasingly used. A study has shown that it is technically simpler and assumes less painful than the classic pose. It seems interesting to compare the pain felt by the patients during IUD / IUS insertion in these two methods of placement and also to confirm that there is no more malposition with the direct method.

Detailed description

The classic method uses: a Pozzi for pulling the uterus to horizontalize it and a hysterometer to visualize the axis of the uterus and to measure the distance between the external orifice of the cervix and the uterine fundus in order to deploy the IUD / IUS. In the so-called direct technique, the operator does not measure the depth of the uterus thanks to a hysterometer and does not draw the cervix with a Pozzi forceps, the IUD / IUS is deployed as soon as the orifice passes. inside the cervix and the inserter tube does not enter the uterine cavity. With this method the Pozzi forceps is only used as a second line, especially in case of a fleeing neck.

Interventions

* Put the Pozzi forceps to draw the uterus by the cervix to horizontalize it and align uterine cavity in the direct axis of cervix. * Insert the hysterometer to measure the uterus depth. * Locate the uterine depth on the inserter tube.

* Place the ring on the inserter tube 3 to 4 cm from the end as a marker. * Insert the tube into the cervix until you feel the passage of the internal orifice of the cervix or until the ring is in contact with the external orifice of the cervix, the tube does not enter the uterine cavity

Sponsors

URC-ECO Clinical trial unit on health Economics, Hotel-Dieu Hospital
CollaboratorUNKNOWN
EA 7334 Patient-Centered Outcomes Research, University Paris-Diderot
CollaboratorUNKNOWN
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* The study population will concern all women aged 18 to 50 who want IUD or SIU contraception regardless of whether they are nulliparous, primiparous or pluriparous, whether or not they have had an IUD or IUS. * Having signed informed consent. * Being affiliated to a social security scheme (excluding AME)

Exclusion criteria

* Can not express their consent * Not mastering French * With a contraindication to the chosen IUD or IUS. * Having had local anesthesia of the cervix (in case of Voluntary Interruption of Pregnancy on the day of insertion) * Having received analgesic treatment within four hours * Patient without social security * No consent of the patient * Minor patient

Design outcomes

Primary

MeasureTime frameDescription
Pain level during the insertion of IUD or IUSduring the procedure of IUD/IUS insertionEvaluation endpoint is pain felt by the patient during insertion of the IUD or IUS by a 0-100 mm standard visual analog scale (VAS)

Secondary

MeasureTime frameDescription
IUD or SIU localizationUltrasound control performed six to ten weeks after the pose.localization of IUD/IUS will be controlled by a pelvic ultrasound

Countries

France

Contacts

Primary ContactCatherine Soulat, doctor
catsoulat@wanadoo.fr+33668343890
Backup ContactCharlotte Rambault
charlotte.rambault@laposte.net+33619430824

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026